Tajima H, Okazaki M, Yamaguchi T, Ohbatake Y, Okamoto K, Nakanuma S, Terai S, Sakai S, Kinoshita J, Makino I, et al. Phase I study of third-line palliative chemotherapy with low dose paclitaxel for pancreatic cancer. Molecular and clinical oncology. 2018. 8. 4. 523-527
2001 - 2001 An award from Japanese College of Surgeons :Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas-ligand.--- a potent mechanism for immune escape.
1999 - 膵臓病研究
Association Membership(s) (9):
International Association of Pancreatology
, 日本臨床外科医学会
, 日本消化器内視鏡学会
, 日本消化器病学会
, 日本胆道学会
, 日本膵臓学会
, 日本肝臓学会
, 日本消化器外科学会
, 日本外科学会